Geoffrey Grammer, MD closes this series highlighting the administration options of esketamine, its safety profile, and the importance of monitoring patients using this treatment.
Semaglutide Not Linked to Suicidal Risks in Those Without Major Psychiatric Disorders
The Physician Burnout Crisis, with Sue Padernacht, EDd, PCC
Phase 2 Data Supports the Effectiveness, Safety of NBI-1117568 for Schizophrenia
John J. Miller, MD: A New Era For Psychiatric Medications
Semaglutide Linked to Suicidal Ideation, New Study Reveals
Unvaccinated People at Risk of Facing Mental Illness Up to a Year After COVID-19